Reports expansion of CompuFlo® Epidural System across additional pain management clinics and ambulatory surgery centers following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Apri ...

Köln (ots) - Grüzi und Sali, liebe Schweiz! Drei Tage vor dem Finale des Eurovision Song Contest 2025 meldet sich Stefan Raab mit einer Liveshow aus der Schweiz: "Chefsache ESC 2025 - Live aus Basel" ...

Honored with multiple category awards underscoring Sumsub's ongoing commitment to innovation and efforts in combating financial crime LONDON, April 16, 2025 /PRNewswire/ -- Sumsub, a global ...

London (ots/PRNewswire) - North America's 50 Best Bars 2025, gesponsert von Perrier, hat die erste 51-100 Liste veröffentlicht. Diese erweiterte Liste ist das Ergebnis der Stimmen, die von der Wahl-Ak ...

North America's 50 Best Bars 2025, sponsored by Perrier, has revealed the inaugural 51-100 list. This extended list is the result of the votes cast by ...

Duni Group announces that the company's complete Annual- and Sustainability Report for 2024, in English and Swedish, is now available at the company's ...

Leggett & Platt (NYSE:LEG), a diversified manufacturer of engineered products serving several major markets, will release first quarter earnings results ...

Vaduz (ots) - Mit über 400 führenden Entscheidungsträgerinnen und Entscheidungsträgern aus Wirtschaft, Politik und Wissenschaft hat sich der Vaduzer-Saal am 15. April 2025 erneut in das Zentrum der di ...

Orion Innovation ("Orion"), a leading digital transformation and product development services firm, was named in Everest Group's prestigious PEAK ...

LONDON, Ontario, April 15, 2025. ("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like wast ...

WELL achieved annual revenue of $919.7 million in 2024, an increase of 19% compared to the prior year. Under applicable IFRS standards, revenue was negatively impacted ...

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment ...